Asian markets ended mostly higher on Friday with expectations that Japan, US and Europe countries will deliver large-scale additional stimulus measures. However, Japanese shares ended lower after reports that US drug-maker Pfizer is dialing back its Covid-19 vaccine rollout plan for this year due to supply chain problems. Meanwhile, Chinese shares ended almost flat on escalating tensions between the world's two largest economies after the US added Chinese chipmaker SMIC and oil giant CNOOC to a blacklist of alleged Chinese military companies.
Asian Indices | Last Trade | Change in Points | Change in % |
Shanghai Composite | 3,444.58 | 2.44 | 0.07 |
Hang Seng | 26,835.92 | 107.42 | 0.40 |
Jakarta Composite | 5,810.48 | -12.46 | -0.21 |
KLSE Composite | 1,621.85 | -6.41 | -0.39 |
Nikkei 225 | 26,751.24 | -58.13 | -0.22 |
Straits Times | 2,839.89 | 17.55 | 0.62 |
KOSPI Composite | 2,731.45 | 35.23 | 1.31 |
Taiwan Weighted | 14,132.44 | 155.35 | 1.11 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: